Crucially, the long-acting insulin was no worse than Tresiba when it came to rates ... in glucose-lowering efficacy with a similar safety profile. After those trial results were published ...

This is largely thanks to strong performances from GLP-1 analogue Victoza, insulin analogue Levemir and the 2015 launch of longer-acting insulin analogue Tresiba. Other companies rising strongly ...

ST. PAUL (Valley News Live) - Attorney General Keith Ellison announced a settlement with Novo Nordisk that guarantees that all Minnesotans, with or without insurance, can buy Novo Nordisk’s ...

A thorough examination of modern drugs that target particular receptors and metabolic pathways for glucose and fat metabolism is presented. Recent research has revealed innovative targets and ...

It also caps insulin costs at $35 per month for Medicare beneficiaries and a $2,000 out-of-pocket annual cap for people enrolled in a certain drug plan. Trump's reversal of the 2022 "Lowering ...

Minnesota Attorney General Keith Ellison on Monday announced a settlement in a lawsuit against insulin manufacturer Novo Nordisk. Minnesota residents will now be able to get Novo Nordisk insulin ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two ...

Civica independently announced it would produce insulin by 2024. It is possible for the FDA to fast-track drug applications that are high-profile or politically sensitive like insulin, pharmaceutical ...

“Without insulin, I die.” Novo Nordisk manufactures insulin products like NovoLog, Tresiba, Fiasp and Novolin. Novo Nordisk will also provide free insulin to qualifying patients below a ...

The company will also provide free insulin for Minnesotans who are the most in need. Those products include Novolog, Tresiba, Fiasp, and Novolin. Monday’s settlement resolves Attorney General ...